Covidh Technologies Limited has officially been renamed to iSERA Lifesciences Limited following approval from the Ministry of Corporate Affairs (MCA) with effect from April 10, 2026. The company informed BSE Limited about the name change approval under Regulation 30 of SEBI Listing Regulations.

MCA Approval and Certificate Issuance

The Registrar of Companies, Pune, Ministry of Corporate Affairs approved the name change from "Covidh Technologies Limited" to "iSERA Lifesciences Limited" on April 10, 2026. A fresh Certificate of Incorporation was issued by the Central Processing Centre, signed digitally by Assistant Registrar Prerna Panwar.

Corporate Timeline and Approvals

The name change process involved multiple regulatory steps. The Board of Directors initially approved the name change proposal on March 10, 2026, followed by an Extraordinary General Meeting notice. Subsequently, on April 02, 2026, shareholders passed a Special Resolution approving the company name change during the 1st Extra-Ordinary General Meeting.

Company Secretary and Compliance Officer Deepakshi (Membership No.: A76335) submitted the intimation to BSE Limited's Department of Corporate Services on April 10, 2026. The submission included the fresh Certificate of Incorporation issued by MCA as supporting documentation.

Memorandum and Articles Amendment

The company's Memorandum of Association and Articles of Association have been altered to reflect the name change. According to MCA regulations, the company must display its former name "Covidh Technologies Limited" alongside the new name "iSERA Lifesciences Limited" for a period of two years at all places where the company name is required to be displayed under Section 12 of the Companies Act.

Updated Corporate Information

The company operates from Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001. The original incorporation was under the name "Aarya Consultants Private Limited" before the current transformation to iSERA Lifesciences Limited.

Previous Compliance Activities

Prior to the name change approval, the company had submitted its quarterly compliance certificate to BSE Limited for Q4FY26 ended March 31, 2026. The certificate, issued by Registrar and Share Transfer Agent Skyline Financial Services Private Limited, confirmed that no physical share certificates were received for dematerialization during the quarter, maintaining compliance with SEBI Regulation 74(5).

Covidh Technologies Limited has released the detailed scrutinizer's report and voting results for its Extra-Ordinary General Meeting held on April 02, 2026, showing unanimous shareholder approval for all proposed resolutions including the company name change to iSERA Lifesciences Limited and new director appointments.

Meeting Overview and Regulatory Compliance

The EGM was conducted through video conferencing from 12:00 P.M. to 12:12 P.M. (IST) with Ms. Jayshree Suresh Jain, Managing Director, chairing the proceedings. A total of 25 public shareholders attended via video conferencing, while no promoter shareholders attended in person or via proxy. The meeting was held in compliance with Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mr. Anuj Gupta, Practising Company Secretary (Membership No. 31025), served as the scrutinizer and issued the consolidated report on April 03, 2026. Remote e-voting was available from March 30, 2026, at 9:00 A.M. (IST) through April 01, 2026, at 5:00 P.M. (IST), with services provided by MUFG Intime India Private Limited.

Voting Results and Unanimous Approval

All five resolutions received 100% approval from voting shareholders, with no votes cast against any resolution. The voting breakdown shows strong support across both promoter and public categories:

Major Corporate Changes Approved

The most significant resolution involved changing the company name from Covidh Technologies Limited to iSERA Lifesciences Limited, which was approved as a special resolution. This name change also necessitated consequential alterations to the company's Memorandum of Association and Articles of Association.

New Board Appointments

Shareholders approved the appointment of four new directors through ordinary resolutions, representing a significant expansion of the company's board structure:

The appointments add two executive directors and two non-executive directors to strengthen corporate governance and operational oversight. All director appointment resolutions were categorized as having promoter group interest.

Regulatory Documentation and Compliance

The company submitted the voting results and scrutinizer's report to BSE Limited on April 03, 2026, in compliance with regulatory requirements. The documentation was digitally signed by Deepakshi, Company Secretary & Compliance Officer (Mem. No. A76335), and countersigned by the meeting chairperson.

The company maintains its registered office at Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001, with corporate office located at Office No. 4, Kumar Prestige Point, 238 Shukrawar Peth, Pune City, Maharashtra – 411002. All proceedings were conducted in full compliance with Section 108 of the Companies Act, 2013, and Rule 20 of the Companies (Management and Administration) Rules, 2014.